{"id":"W4321793664","doi":"10.1016/j.jtocrr.2023.100482","title":"Impact of Performance Status on Survival Outcomes and Health Care Utilization in Patients With Advanced NSCLC Treated With Immune Checkpoint Inhibitors","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Performance status; Pembrolizumab; Internal medicine; Nivolumab; Emergency department; Oncology; Immunotherapy; Cancer; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001800952,0.0001225211,0.000472026,0.0002192958,0.00007900366,0.00001126475,0.00002174059,0.00007339064,0.000008248023],"category_scores_gemma":[0.0002222903,0.00006411949,0.00006293181,0.000619415,0.0003169252,0.0000643398,0.00003450985,0.0002933677,3.931385e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001355376,"about_ca_system_score_gemma":0.0004816002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060261,"about_ca_topic_score_gemma":0.0001796821,"domain_scores_codex":[0.9978284,0.000122593,0.0007000918,0.0003220414,0.0006792292,0.0003476922],"domain_scores_gemma":[0.9989073,0.0001375008,0.0001956444,0.000244478,0.0003365498,0.0001785563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009633495,0.0002513454,0.905001,0.0001438946,0.00007807264,0.0000449945,0.0002465676,0.000005027886,0.00002631837,4.091513e-7,0.00002385703,0.08454498],"study_design_scores_gemma":[0.005816806,0.01227145,0.9807138,0.0005490414,0.000006608501,0.00000402477,0.000277713,0.00001690613,0.0001322944,0.000001409028,0.0001361839,0.00007372022],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983886,0.0003482389,3.099327e-7,0.0002680906,0.00004560785,0.0007516809,0.00000820539,0.00002117561,0.0001680174],"genre_scores_gemma":[0.9978762,0.0018535,0.00001678188,0.00001570117,0.00001533938,0.00001644313,0.00008757498,0.0000162215,0.000102219],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08447126,"threshold_uncertainty_score":0.2614717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1030508635146237,"score_gpt":0.4667007910321048,"score_spread":0.363649927517481,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}